Analysis
Public drug policy for children in Canada
Avram E. Denburg, Wendy J. Ungar and Mark Greenberg
CMAJ July 31, 2017 189 (30) E990-E994; DOI: https://doi.org/10.1503/cmaj.170380
Avram E. Denburg
Division of Haematology/Oncology (Denburg, Greenberg); Child Health and Evaluative Sciences (Denburg, Ungar), Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children; Institute for Health Policy, Management and Evaluation (Ungar), University of Toronto; Pediatric Oncology Group of Ontario (Greenberg), Toronto, Ont.
MD MScWendy J. Ungar
Division of Haematology/Oncology (Denburg, Greenberg); Child Health and Evaluative Sciences (Denburg, Ungar), Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children; Institute for Health Policy, Management and Evaluation (Ungar), University of Toronto; Pediatric Oncology Group of Ontario (Greenberg), Toronto, Ont.
MSc PhDMark Greenberg
Division of Haematology/Oncology (Denburg, Greenberg); Child Health and Evaluative Sciences (Denburg, Ungar), Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children; Institute for Health Policy, Management and Evaluation (Ungar), University of Toronto; Pediatric Oncology Group of Ontario (Greenberg), Toronto, Ont.
MBChB
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Public drug policy for children in Canada
Avram E. Denburg, Wendy J. Ungar, Mark Greenberg
CMAJ Jul 2017, 189 (30) E990-E994; DOI: 10.1503/cmaj.170380
Jump to section
Related Articles
- No related articles found.